EISAI

HQ - Tokyo

Summary

Eisai is a pharmaceutical company that focuses on discovering, developing, and commercializing innovative products for the treatment of various diseases, including neurology and oncology.

Deals Overview

Total Deals3

Valued Deals2

Total Value£ 84 M

Avg. Deal Size£ 42 M

Market Context

Senior Management

Haruo Naito
CEO
Keisuke Naito
Senior Vice President